Latest Strategy News

Data#3 Limited reported a robust first half for FY26 with gross sales rising 9.1% to $1.55 billion and net profit climbing 3.7% to $23.17 million, underpinned by strong demand in infrastructure and AI-related solutions.

DigitalX Limited is launching a strategic investment program with up to A$30 million to diversify beyond Bitcoin accumulation, targeting profitable digital asset infrastructure businesses.

Gorilla Gold reports a standout 49m intercept at 2.5g/t gold outside the current Sovereign Deposit resource, signalling fresh growth potential at its Comet Vale project in Western Australia.

Locksley Resources has initiated diamond drilling at its Desert Antimony Mine in California, aiming to expand known high-grade mineralisation and support US critical minerals supply chains.

Vital Metals has reported exceptional surface assay results from its Nechalacho Rare Earths and Niobium Project in Canada, revealing ultra-high-grade mineralisation beyond its flagship Tardiff deposit. These findings underpin an aggressive resource expansion strategy ahead of a 2027 Pre-Feasibility Study.

Celsius Resources has raised A$9.3 million through a well-supported institutional placement, strengthening its balance sheet to advance the financing and early development of its flagship MCB copper-gold project in the Philippines.

GR Engineering Services has been named preferred contractor for the $225 million Tower Hill Gold Project near Leonora, marking a significant milestone in its mining sector portfolio.

Andean Silver Limited has appointed Matthew Allen as CEO, marking a strategic leadership shift to accelerate development at its Cerro Bayo silver-gold project. Former CEO Tim Laneyrie transitions to Technical Director to focus on exploration and resource expansion.

Tinybeans Group announces a leadership reshuffle with Tracy Cho as Interim CEO and Rebecca White joining the Board, sharpening its focus on expanding in the lucrative U.S. family market.

Argent BioPharma has completed its largest commercial shipment of CannEpil® to Ireland, marking a key milestone in its European expansion with a delivery valued at approximately AUD 783,000. The product is fully reimbursed under Ireland’s National Health Insurance scheme, enhancing patient access for refractory epilepsy treatment.

Mayne Pharma has announced a planned leadership transition with CFO Aaron Gray stepping up as CEO, succeeding Shawn Patrick O’Brien who will remain as an advisor during the handover.

Navigator Global Investments reported a 17% rise in adjusted EBITDA to USD48.2 million for H1 FY26, driven by strong performance fees and asset growth, though full-year earnings face headwinds.